1.Use of One-step Nucleic Acid Amplification® and ultrasonography to predict metastasis in non-sentinel lymph node in breast cancer
Taeko KANAMORI ; Satoru FURUTA ; Youko SANADA ; Sho YAGI ; Kazuhiro ISHIHARA ; Harumi TAKAHASHI ; Atsuko YAMADA ; Hidenori TANAKA ; Satoru YAMAMOTO
Journal of the Japanese Association of Rural Medicine 2016;64(6):1049-1053
Although axillary lymph node dissection (ALND) is conventionally indicated for metastasis in the sentinel lymph node (SLN), the omission of ALND is being discussed more often in recent years. However, because of the lack of specific guidelines, it is unclear which cases should be treated without ALND. In this study, we performed one-step nucleic acid amplification of the SLN with metastasis to determine the total tumor load (TTL), that is, the number of cytokeratin (CK) 19 mRNA copies. After ultrasonography (US) of ALN, the ultrasonographic findings were combined with TTL to rate SLN metastasis. In the rating, a total score was obtained by assigning 1 point each for (a) TTL of ≥15000 copies/μL, (b) US findings of a long-to-short LN diameter ratio of ≤2, and (c) US findings of no echogenic hilus. We then investigated the association between the total score and metastasis in the non-SLN. Results showed that while 87.5% (5/6) of patients with positive non-SLN scored ≥2 points, only 3.1% (1/34) of patients with negative non-SLN did so, suggesting that a total copy number of CK19 mRNA, US findings of a long-to-short LN diameter ratio, and the presence/absence of echogenic hilus are important predictors for non-SLN metastasis. This novel scoring system is expected to help determine which patients need ALND or what postoperative therapy is necessary.
2.Effects of Vaccination Against Influenza Administered by Our Hospital: A 3-Year Retrospective Study
Hiroyuki OHBAYASHI ; Takenori HARADA ; Fusao HIRAI ; Tsugiyou MATSUSHITA ; Satoru FURUTA ; Akira SASAKI ; Hiroyuki NOSAKA ; Hirohiko YAMASE
Journal of the Japanese Association of Rural Medicine 2005;54(5):749-755
To review the outcome of our vaccination program against influenza, an investigation was made into the incidence of this acute infectious disease in our community from 2002 through 2004.Enrolled for this retrospective study were 1) all vaccinated individuals, 2) those who underwent nasal examinations by use of the swab, and 3) patients diagnosed as contracting influenza.The number of those administered with influenza virus vaccines increased year after year during the period under review. Over 70% of them were those aged 65years or above. The mean age of those who caught influenza was 42.9±21.3 in 2002, 34.9±20.4 in 2003 and 45.4±20.2 in 2004. Compared with unvaccinated old people, many unvaccinated young and middle-aged people contracted influenza, but among the vaccinated old people, there were some who came down with the flu.Morbidity was low for the old people whose vaccination rate was high.Therefore, it can be said that vaccination was effective in achieving adequate immunity. Nonetheless, for all the preventive injection, the fact that people of advanced age could be infected should be taken note of.
Influenza
;
Vaccination
;
Retrospective Studies
;
Review [Publication Type]
;
Hospitals
3.A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry.
Satoru JOSHITA ; Koh NAKAZAWA ; Shoichiro KOIKE ; Atsushi KAMIJO ; Kiyoshi MATSUBAYASHI ; Hideharu MIYABAYASHI ; Kiyoshi FURUTA ; Kiyoshi KITANO ; Kaname YOSHIZAWA ; Eiji TANAKA
Journal of Korean Medical Science 2010;25(3):476-480
Granulocyte-colony stimulating factor (G-CSF) is a naturally occurring glycoprotein that stimulates the proliferation and maturation of precursor cells in the bone marrow into fully differentiated neutrophils. Several reports of G-CSF-producing malignant tumors have been published, but scarcely any in the hepatobiliary system, such as in hepatocellular carcinoma (HCC). Here, we encountered a 69-yr-old man with a hepatic tumor who had received right hepatic resection. He showed leukocytosis of 25,450/microL along with elevated serum G-CSF. Histological examination of surgical samples demonstrated immunohistochemical staining for G-CSF, but not for G-CSF receptor. The patient survived without recurrence for four years, but ultimately passed away with multiple bone metastases. In light of the above, clinicians may consider G-CSF-producing HCC when encountering patients with leukocytosis and a hepatic tumor. More cases are needed to clarify the clinical picture of G-CSF-producing HCC.
Aged
;
Bone Neoplasms/secondary
;
Carcinoma, Hepatocellular/*metabolism/pathology
;
Fatal Outcome
;
Granulocyte Colony-Stimulating Factor/*metabolism
;
Humans
;
Liver Neoplasms/*metabolism/pathology
;
Male
;
Receptors, Granulocyte Colony-Stimulating Factor/metabolism